Reducing Problematic Substance Use in Youth With Chronic Medical Conditions

Not Applicable

Withdrawn

• Conditions: Drug Abuse; Alcohol Abuse
• Interventions: Behavioral: Brief Intervention

• Registration Number: NCT01709201
• Lead Sponsor: Boston Children's Hospital

Brief Summary

The investigators goal is to pilot a substance use-related brief intervention (BI) for youth with chronic medical conditions, obtaining preliminary evidence of feasibility, acceptability and impacts of the approach for reducing substance use among this group.

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2012-10-15
• Study First Submitted QC: 2012-10-17
• Study First Posted: 2012-10-18
• Study Start: 2013-07
• Primary Completion: 2014-12
• Study Completion: 2015-06
• Status Verified: 2017-06
• Last Update Submitted: 2017-06-19
• Last Update Posted: 2017-06-21

Recruitment & Eligibility

• Status: WITHDRAWN
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

• 14-18 years old
• Currently being treated for diabetes, rheumatologic disorders, asthma, or ulcerative colitis (UC) at Boston Children's Hospital with a duration of chronic illness of at least one year
• Previous participation in the screening validation study
• Evidence of problems related to substance use

Exclusion Criteria

• Medically or emotionally unstable or otherwise unable to provide assent/consent
• Unable to speak/read English
• Unable to use a computer keyboard and/or complete an interviewer-assisted questionnaire

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
Brief Intervention	Brief Intervention	Those in the Brief Intervention group will receive a brief motivational intervention aimed at encouraging the participant to decrease their substance use.

Primary Outcome Measures

Name	Time	Method
Percent days abstinent	30 days post baseline	We will compare the percent days abstinent from substances between the Treatment as Usual and Intervention groups 30 days post baseline

Secondary Outcome Measures

Name	Time	Method
Medical complications	30 days post baseline	We will evaluate the incidents of disease complications between the Treatment as Usual and Intervention groups 30 days post baseline

Trial Locations

Locations (1)

Boston Children's Hospital; 🇺🇸 Boston, Massachusetts, United States